Can I Take Folate with Jatenzo?

No Direct Drug-Supplement Interaction Exists

Folate (vitamin B9) and Jatenzo operate through entirely separate metabolic pathways, and no published pharmacokinetic or pharmacodynamic interaction has been identified between the two. Jatenzo is absorbed through the intestinal lymphatic system, bypassing first-pass hepatic metabolism [1]. Folate is absorbed primarily in the proximal jejunum via proton-coupled folate transporters [2].

Why the Pathways Don't Overlap

Jatenzo's active ingredient, testosterone undecanoate, is a lipophilic ester that requires co-ingestion with dietary fat. The drug is packaged in a self-emulsifying formulation that promotes lymphatic uptake rather than portal venous absorption [1]. This unusual absorption route means it largely avoids the cytochrome P450 system during its initial pass into systemic circulation.

Folate, by contrast, is a water-soluble B vitamin. It does not rely on lymphatic absorption or CYP450 metabolism. Once absorbed, folate is converted to tetrahydrofolate (THF) and then to 5-methyltetrahydrofolate (5-MTHF) by the enzyme methylenetetrahydrofolate reductase (MTHFR) [2]. These two compounds simply do not compete for the same transporters, enzymes, or binding proteins.

What the Databases Say

The Natural Medicines Comprehensive Database, Lexicomp, and the FDA-approved Jatenzo prescribing information do not list folate or folic acid as an interacting substance [1][3]. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy for men with hypogonadism does not flag B-vitamin supplementation as a concern during TRT [4].

Why Folate Might Actually Help During Testosterone Therapy

Testosterone replacement therapy (TRT), including Jatenzo, can raise plasma homocysteine concentrations. A 2006 study in the Journal of Clinical Endocrinology & Metabolism (N=50) found that testosterone administration increased homocysteine levels by a mean of 1.4 µmol/L over 6 months in hypogonadal men [5]. Elevated homocysteine is an independent risk factor for cardiovascular disease [6].

The Homocysteine-Folate Connection

Folate is the primary dietary regulator of homocysteine metabolism. The remethylation of homocysteine to methionine requires 5-MTHF as a methyl donor and vitamin B12 as a cofactor [2]. A meta-analysis published in the BMJ (25 randomized trials, N=2,596) demonstrated that folic acid supplementation at doses of 0.5-5 mg/day reduced blood homocysteine concentrations by approximately 25% [7].

For men starting Jatenzo, maintaining adequate folate status may help offset the homocysteine-raising effect of exogenous testosterone. This is not a treatment for cardiovascular disease. It is a rational nutritional strategy based on known biochemistry.

Cardiovascular Context for Jatenzo Specifically

The FDA requires a boxed warning on Jatenzo regarding the potential for increased blood pressure, which may raise cardiovascular risk [1]. In the Jatenzo phase 3 trial (N=166), systolic blood pressure increased by a mean of 3.4 mmHg at 12 months [8]. Given this cardiovascular signal, managing modifiable risk factors like homocysteine through adequate folate intake is a reasonable adjunctive measure.

MTHFR Variants and Jatenzo: A Special Consideration

Men who carry MTHFR polymorphisms face a compounded situation when starting testosterone therapy. The C677T variant reduces MTHFR enzyme activity by approximately 30% in heterozygotes and up to 70% in homozygotes [9]. This means less efficient conversion of folic acid to its active 5-MTHF form, leading to higher baseline homocysteine.

Who Should Be Tested

The American Heart Association does not recommend universal MTHFR screening [6]. Testing becomes clinically relevant when a patient on TRT presents with unexplained elevations in homocysteine (above 15 µmol/L), a personal or family history of early cardiovascular events, or a history of venous thromboembolism [9]. The Endocrine Society's 2018 guideline already recommends monitoring hematocrit and cardiovascular risk markers during testosterone therapy [4], and adding homocysteine to that panel is a low-cost addition.

Methylfolate vs. Folic Acid

For men with confirmed MTHFR C677T homozygosity, supplementing with L-methylfolate (5-MTHF) at 1,000 mcg daily bypasses the impaired enzymatic step entirely [9]. Standard folic acid (pteroylmonoglutamic acid) requires MTHFR to become bioactive, making it less effective in this population. A randomized crossover trial (N=160) published in the American Journal of Clinical Nutrition found that 5-MTHF was 1.8 times more effective at raising plasma folate in MTHFR TT homozygotes compared to equimolar folic acid [10].

Men without MTHFR variants can use either form. The NIH Office of Dietary Supplements recommends 400 mcg DFE (dietary folate equivalents) daily for adult men [11].

Dosing and Timing: No Separation Needed

Because folate and Jatenzo do not share absorption pathways or metabolic enzymes, there is no pharmacological reason to separate their doses. Both can be taken at the same meal.

Practical Dosing Schedule

Jatenzo must be taken twice daily with food containing at least 30 grams of fat for adequate absorption [1]. A typical regimen looks like this:

• Morning with breakfast (containing fat): Jatenzo 198-396 mg + folate 400-1,000 mcg
• Evening with dinner (containing fat): Jatenzo 198-396 mg

Taking folate with the morning dose of Jatenzo is the simplest approach. Folate is water-soluble and absorbed quickly regardless of fat content, so pairing it with the fat-rich meal required by Jatenzo is a matter of convenience, not necessity.

What About Other B Vitamins?

Folate works in concert with vitamin B12 and vitamin B6 in the homocysteine metabolic pathway [2]. Supplementing folate alone without adequate B12 can theoretically mask B12 deficiency by correcting the megaloblastic anemia while allowing neurological damage to progress [11]. The NIH recommends that any folate supplementation above 400 mcg be paired with B12 status assessment [11]. For men on TRT who are also supplementing folate, checking serum B12 at baseline is a straightforward safeguard.

Monitoring Recommendations on TRT Plus Folate

The Endocrine Society's 2018 guideline recommends the following monitoring schedule for men on testosterone therapy: hematocrit at 3-6 months, then annually; PSA at 3-12 months for men over 40; lipid panel at 6-12 months [4]. When adding folate to this regimen, a few additional markers are worth tracking.

Baseline Labs Before Starting

Before initiating Jatenzo with folate supplementation, obtain:

• Complete blood count (CBC) with hematocrit
• Homocysteine level
• Serum folate and B12
• Comprehensive metabolic panel

Ongoing Monitoring

At 3 months, recheck hematocrit and homocysteine. Jatenzo's prescribing information notes that hematocrit elevations above 54% occurred in 3.6% of patients in the key trial and require dose reduction or discontinuation [1][8]. Folate supports erythropoiesis (red blood cell formation), which creates a theoretical additive effect on red cell mass when combined with the erythropoietic stimulus of testosterone [12].

This does not mean folate is dangerous on TRT. The effect of physiologic folate supplementation (400-1,000 mcg) on hematocrit is minimal in isolation. But when testosterone is already pushing hematocrit upward, tracking it more closely during the first 6 months is prudent clinical practice.

At 6 and 12 months, repeat CBC, homocysteine, and standard TRT monitoring labs. If homocysteine normalizes and hematocrit remains below 54%, annual monitoring is sufficient thereafter.

Anticonvulsant Use: A Third Variable

Some men on Jatenzo also take anticonvulsant medications (phenytoin, carbamazepine, valproate) for seizure disorders, neuropathic pain, or mood stabilization. Multiple anticonvulsants are well-documented folate antagonists. Phenytoin reduces serum folate by inhibiting intestinal absorption and accelerating hepatic folate catabolism [13].

When All Three Overlap

If a patient takes Jatenzo, an anticonvulsant, and folate simultaneously, two concerns arise. First, the anticonvulsant may reduce folate bioavailability, requiring higher supplemental doses (typically 1-5 mg/day rather than the standard 400 mcg) [13]. Second, certain anticonvulsants like phenytoin and carbamazepine are potent CYP3A4 inducers. While Jatenzo's lymphatic absorption route partially shields it from CYP3A4-mediated interactions, the FDA label does note that strong CYP3A4 inducers may reduce testosterone undecanoate exposure [1].

The 2018 Endocrine Society guideline states: "Clinicians should be aware that certain medications, including anticonvulsants, may alter sex hormone-binding globulin (SHBG) concentrations and affect total testosterone levels" [4]. Men on anticonvulsants who are also taking Jatenzo should have their testosterone levels monitored more frequently (every 3 months initially) and their folate dose adjusted based on serum levels.

What If You Are Already Taking Both?

If you have been taking folate alongside Jatenzo without issues, there is no reason to stop. Review your most recent lab work with your prescribing physician. Key values to check: hematocrit (target below 54%), homocysteine (target below 15 µmol/L, ideally below 10), and serum folate (normal range 3-20 ng/mL) [4][11].

Signs to Watch For

Contact your physician if you experience:

• Persistent headaches or visual changes (possible polycythemia)
• Chest pain or leg swelling (thrombotic event signs)
• New numbness or tingling in extremities (possible B12 deficiency if supplementing folate without B12)

These symptoms are not specific to the folate-Jatenzo combination. They relate to known TRT risks that any patient on testosterone therapy should understand.

Folate Food Sources vs. Supplements on TRT

Dietary folate from whole foods (dark leafy greens, legumes, liver, fortified grains) is well-absorbed and carries no risk of masking B12 deficiency at typical dietary intakes [11]. The U.S. Mandatory folic acid fortification program, implemented in 1998, reduced neural tube defect rates by 28% and also lowered population-level homocysteine concentrations [14].

For men on Jatenzo who eat a balanced diet rich in folate-containing foods, additional supplementation may be unnecessary unless homocysteine is elevated or an MTHFR variant is confirmed. A single cup of cooked lentils provides approximately 358 mcg of folate, nearly meeting the adult RDA [11].

Men with restricted diets, malabsorption conditions, or confirmed MTHFR variants should supplement with methylfolate (5-MTHF) at 400-1,000 mcg daily alongside their Jatenzo regimen.

The Bottom Line on Folate and Jatenzo

No pharmacokinetic or pharmacodynamic interaction exists between folate and Jatenzo. Men on oral testosterone undecanoate can take folate safely, and doing so may help manage homocysteine levels that TRT tends to raise. Use methylfolate if you carry MTHFR C677T. Monitor hematocrit at 3 and 6 months, then annually. Check homocysteine at baseline and at 6 months. The recommended daily folate intake for adult men is 400 mcg DFE, with doses up to 1,000 mcg appropriate for MTHFR homozygotes or men on anticonvulsants [4][11].